IL197982A0 - Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory - Google Patents
Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theoryInfo
- Publication number
- IL197982A0 IL197982A0 IL197982A IL19798209A IL197982A0 IL 197982 A0 IL197982 A0 IL 197982A0 IL 197982 A IL197982 A IL 197982A IL 19798209 A IL19798209 A IL 19798209A IL 197982 A0 IL197982 A0 IL 197982A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- cardiovascular diseases
- combined preparation
- diseases based
- chronotherapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20060098438 | 2006-10-10 | ||
KR1020070101492A KR100888131B1 (en) | 2006-10-10 | 2007-10-09 | Combination preparation for Cardiovascular disease therapy by Chronotherapy theory. |
PCT/KR2007/004929 WO2008044862A1 (en) | 2006-10-10 | 2007-10-10 | Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory |
Publications (1)
Publication Number | Publication Date |
---|---|
IL197982A0 true IL197982A0 (en) | 2009-12-24 |
Family
ID=39533338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL197982A IL197982A0 (en) | 2006-10-10 | 2009-04-05 | Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory |
Country Status (2)
Country | Link |
---|---|
IL (1) | IL197982A0 (en) |
ZA (1) | ZA200903204B (en) |
-
2009
- 2009-04-05 IL IL197982A patent/IL197982A0/en unknown
- 2009-05-08 ZA ZA200903204A patent/ZA200903204B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200903204B (en) | 2010-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL186749A0 (en) | Dihydrothienopyrimidines for the treatment of inflammatory diseases | |
EP2005168A4 (en) | Methods and compositions for the diagnosis of diseases of the aorta | |
EP2118074A4 (en) | Compounds for the prevention and treatment of cardiovascular diseases | |
IL202664A (en) | Processes for the preparation of 3-dihalomethyl-1-methyl-1h- pyrazole-4-carbaldehyde and intermediates | |
PT2546253E (en) | Substituted dihydropyrazolones for the treatment of cardiovascular and hematological diseases | |
IL193747A0 (en) | New therapeutic combinations for the treatment of depression | |
HK1202558A1 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
PL2056842T3 (en) | Modified-galactosyl ceramide for the treatment of cancerous diseases | |
GB0612096D0 (en) | Functional imaging of the retina | |
ZA200901523B (en) | Use of extracts for the treatment of viral disorders | |
GB0909297D0 (en) | Composition for the treatment of skin conditions | |
GB0611240D0 (en) | The treatment of increased sebum production | |
GB0611241D0 (en) | The treatment of increased sebum production | |
GB0910201D0 (en) | The preparation method of 2-deoxy-l-ribose | |
PL2044099T3 (en) | Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates | |
PL2307380T3 (en) | N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases | |
IL191887A0 (en) | Method for the diagnosis and treatment of cardiovascular diseases | |
HK1185345A1 (en) | Compounds for the prevention and treatment of cardiovascular diseases | |
IL197982A0 (en) | Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory | |
GB0602857D0 (en) | The treatment of sialorrhoea | |
PL381142A1 (en) | The manner of obtaining of glicydol | |
PL383170A1 (en) | The manner of obtaining calcious preparation | |
GB0602858D0 (en) | The treatment of sialorrhoea | |
GB0602855D0 (en) | The Treatment Of Sialorrhoea | |
GB0609792D0 (en) | The treatment of multiple sclerosis |